These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18839140)

  • 1. Once is not enough: clinical trials in sepsis.
    Sweeney DA; Danner RL; Eichacker PQ; Natanson C
    Intensive Care Med; 2008 Nov; 34(11):1955-60. PubMed ID: 18839140
    [No Abstract]   [Full Text] [Related]  

  • 2. Science, medicine and industry: are we getting out of the black hole in sepsis research?
    Suter PM; Takala J
    Intensive Care Med; 2008 Nov; 34(11):1950-4. PubMed ID: 18839139
    [No Abstract]   [Full Text] [Related]  

  • 3. Editors' comments on a new trial of activated protein C for persistent septic shock.
    Mancebo J; Antonelli M
    Intensive Care Med; 2008 Nov; 34(11):1948-9. PubMed ID: 18839138
    [No Abstract]   [Full Text] [Related]  

  • 4. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.
    Finfer S; Ranieri VM; Thompson BT; Barie PS; Dhainaut JF; Douglas IS; Gårdlund B; Marshall JC; Rhodes A
    Intensive Care Med; 2008 Nov; 34(11):1935-47. PubMed ID: 18839141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PROWESS--milestone in lowering sepsis mortality].
    Reinhart K
    Krankenpfl J; 2002; 40(10-12):315. PubMed ID: 12600016
    [No Abstract]   [Full Text] [Related]  

  • 6. Corticosteroids and human recombinant activated protein C for septic shock.
    Colin G; Annane D
    Clin Chest Med; 2008 Dec; 29(4):705-12, x. PubMed ID: 18954704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "All in" for a huge pot: the PROWESS-SHOCK trial for refractory septic shock.
    Barie PS
    Surg Infect (Larchmt); 2007 Oct; 8(5):491-4. PubMed ID: 17999581
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we be using activated protein C to treat severe sepsis?
    Eve RL; Duffy MR
    Br J Hosp Med (Lond); 2009 Aug; 70(8):484. PubMed ID: 19684544
    [No Abstract]   [Full Text] [Related]  

  • 9. [The new aspects of treatment of severe sepsis and septic shock].
    Adukauskiene D; Rimdeika R; Vitkauskiene A; Pilvinis V; Cicinskaite I
    Medicina (Kaunas); 2006; 42(4):265-72. PubMed ID: 16687897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations for management of severe sepsis and septic shock. Surviving sepsis campaign].
    Martin C; Garnier F; Vallet B
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):440-3. PubMed ID: 15826800
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endogenous anticoagulant therapy for sepsis. Success and failure].
    Wiedermann CJ
    Internist (Berl); 2007 May; 48(5):537-42, 544. PubMed ID: 17390117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sepsis therapy -- how effective are the therapy strategies?].
    Brunkhorst F; Reinhart K
    Chirurg; 2008 Sep; 79(9):877-8. PubMed ID: 18942197
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prowess-shock trial: a protocol overview and perspectives.
    Silva E; de Figueiredo LF; Colombari F
    Shock; 2010 Sep; 34 Suppl 1():48-53. PubMed ID: 20523271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is industry guiding the sepsis guidelines? A perspective.
    Durbin CG
    Crit Care Med; 2007 Mar; 35(3):689-91. PubMed ID: 17255867
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of patients with severe sepsis and septic shock: real-life lessons.
    Davidow JS; Brindley PG; Jacka MJ; Gibney RT
    CJEM; 2006 Jul; 8(4):244-5. PubMed ID: 17324301
    [No Abstract]   [Full Text] [Related]  

  • 17. Sepsis and septic shock: inching forwards.
    Cohen J
    Clin Med (Lond); 2009 Jun; 9(3):256-7. PubMed ID: 19634390
    [No Abstract]   [Full Text] [Related]  

  • 18. Xigris is withdrawn from the market. A 10 year odyssey.
    Suter PM
    Minerva Anestesiol; 2011 Dec; 77(12):1128-9. PubMed ID: 22134426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activated protein C in patients with septic shock: contra].
    Graf J
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2371. PubMed ID: 21082531
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.
    Macias WL; Nelson DR; Williams M; Garg R; Janes J; Sashegyi A
    Crit Care; 2005; 9(6):R607-22. PubMed ID: 16280057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.